UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

(Check One)
[ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR

For Period Ended: March 31, 2006

[  ] Transition Report on Form 10-K
[  ] Transition Report on Form 20-F
[  ] Transition Report on Form 11-K
[  ] Transition Report on Form 10-Q
[  ] Transition Report on Form N-SAR
For the Transition Period Ended: ________________________

  Read Instruction (on back page) Before Preparing Form. Please Print or Type.

     Nothing in this form shall be  construed to imply that the  Commission  has
     verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:

--------------------------------------------------------------------------------

PART I - REGISTRANT INFORMATION

National Healthcare Technology, Inc.
--------------------------------------------------------------------------------
Full Name of Registrant:

--------------------------------------------------------------------------------
Former Name if Applicable

1660 Union Street, Suite 200
--------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

San Diego, California 92101
------------------------------------------------------------------------------
City, State, Zip Code



PART II - RULES 12b-25 (b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

   | (a) The reasons  described  in  reasonable  detail in Part III of this form
   | could not be eliminated without unreasonable effort or expense;
   |
   | (b) The subject annual report,  semi-annual  report,  transition  report on
   | Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed
X  | on or before the fifteenth  calendar day following the prescribed due date;
   | or the subject  quarterly  report of transition  report on Form 10-QSB,  or
   | portion thereof will be filed on or before the fifth calendar day following
   | the prescribed due date; and
   |
   | (c) The accountant's  statement or other exhibit required by Rule 12b-25(c)
   | has been  attached if applicable.


PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR or the transition report or portion thereof could not be filed within the
prescribed time period.

As a result of delays in gathering the data  necessary to finalize the financial
statements  and  accompanying  notes of the  Registrant's  Form  10-QSB  for the
quarter  ended March 31, 2006,  the report on form 10-QSB cannot be timely filed
without  unreasonable effort or expense.  The Registrant  anticipates filing its
Form 10-QSB by the extended due date.

PART IV - OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this
notification:

Dave Neville                        (805)              640-6468
----------------------------   -----------------    ---------------
     (Name) (Area Code) (Telephone No.)

(2) Have all other  periodic  reports  required under section 13 or 15(d) of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during  the  preceding  12  months  or for such  shorter  period  that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify  report(s).  []Yes  [X]No

The  registrant's  from 10-KSB for the period ended December 31, 2006.

--------------------------------------------------------------------------------
                                      -2-


(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings  statements to be included in the subject report or portion thereof?  [
[ ]Yes [X]No

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

--------------------------------------------------------------------------------


                      National Healthcare Technology, Inc.
                   ------------------------------------------
                  (Name of Registrant as Specified in Charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.

Date: May 15, 2006                           By: /s/  Ross Lyndon James
      -----------------------------          -----------------------------------
                                             Ross Lyndon James, CEO


                                      -3-